RXi Pharmaceuticals (RXI) Forms $0.60 Double Top; Shorts at Ikang Healthcare Group Ads (KANG) Raised By 5.37%
August 9, 2017 - By Darrin Black
RXi Pharmaceuticals Corp (RXI) formed double top with $0.65 target or 9.00% above today’s $0.60 share price. RXi Pharmaceuticals Corp (RXI) has $13.28M valuation. About 42,672 shares traded. RXi Pharmaceuticals Corp (NASDAQ:RXII) has declined 75.22% since August 9, 2016 and is downtrending. It has underperformed by 91.92% the S&P500.
Ikang Healthcare Group Ads (NASDAQ:KANG) had an increase of 5.37% in short interest. KANG’s SI was 637,600 shares in August as released by FINRA. Its up 5.37% from 605,100 shares previously. With 275,300 avg volume, 2 days are for Ikang Healthcare Group Ads (NASDAQ:KANG)’s short sellers to cover KANG’s short positions. The SI to Ikang Healthcare Group Ads’s float is 1.7%. About 9,804 shares traded. iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) has declined 20.38% since August 9, 2016 and is downtrending. It has underperformed by 37.08% the S&P500.
iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The company has market cap of $973.12 million. The Company’s divisions include medical examinations and other medical services, and dental services. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
